Form 4: Elanco Animal Health CEO Jeffrey Simmons Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units, convertible to common stock, as per a recent SEC Form 4 filing.
Summary
- On April 19, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired deferred stock units.
- These deferred stock units are convertible to common stock or their cash equivalent.
- The transaction involved 213.8409 deferred stock units at a price of $12.95 each.
- Following the reported transaction, Simmons directly owns 1,438.2835 shares of common stock.
- The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The acquisition of stock units by the CEO could be interpreted as a positive sign of confidence, but it's not a major event.
Positives
- The acquisition of deferred stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
Industry Context
Executive compensation through stock and deferred stock units is a common practice in publicly traded companies to align management's interests with those of the shareholders. This filing is a routine disclosure of such transactions.
Comparison to Industry Standards
- Stock-based compensation is a standard practice among publicly traded companies, particularly in the pharmaceutical and animal health industries.
- Companies like Zoetis and Merck Animal Health also utilize stock options and restricted stock units as part of their executive compensation packages.
- The specific terms and amounts of these awards vary based on company size, performance, and individual executive roles.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects executive compensation practices.
- Employees may view the CEO's stock acquisition as a positive sign of company leadership's commitment.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Date of the transaction where deferred stock units were acquired. |
| 04/23/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.